These promoters are demethylated in DNMT3B-deficient lymphoma, but not demethylated in DNMT3B-deficient precancerous thymocytes, which indicates that DNMT3B maintains cytosine methylation in cancer cells. The gene discussed is DNMT3B; the disease is cancer.